Par Drugs And Chemicals Limited - Asset Resilience Ratio

Latest as of March 2024: 3.08%

Par Drugs And Chemicals Limited (PAR) has an Asset Resilience Ratio of 3.08% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check how strategically is Par Drugs And Chemicals Limited's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets

Rs31.31 Million

≈ $338.56K USD Cash + Short-term Investments

Total Assets

Rs1.02 Billion

≈ $10.99 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2024)

This chart shows how Par Drugs And Chemicals Limited's Asset Resilience Ratio has changed over time. See Par Drugs And Chemicals Limited balance sheet independence to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Par Drugs And Chemicals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Par Drugs And Chemicals Limited (PAR) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs31.31 Million	3.08%
Total Liquid Assets	Rs31.31 Million	3.08%

Asset Resilience Insights

Limited Liquidity: Par Drugs And Chemicals Limited maintains only 3.08% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Par Drugs And Chemicals Limited Industry Peers by Asset Resilience Ratio

Compare Par Drugs And Chemicals Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
SIMCERE PHARMAC. GRP LTD F:S2P	Drug Manufacturers - Specialty & Generic	0.44%
Curaleaf Holdings Inc. TO:CURA	Drug Manufacturers - Specialty & Generic	3.73%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%

Annual Asset Resilience Ratio for Par Drugs And Chemicals Limited (2019–2024)

The table below shows the annual Asset Resilience Ratio data for Par Drugs And Chemicals Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-03-31	0.00%	Rs1.00K ≈ $10.81	Rs1.02 Billion ≈ $10.99 Million	-3.38pp
2023-03-31	3.38%	Rs30.02 Million ≈ $324.61K	Rs888.68 Million ≈ $9.61 Million	+2.10pp
2022-03-31	1.27%	Rs10.02 Million ≈ $108.32K	Rs786.90 Million ≈ $8.51 Million	+1.27pp
2019-03-31	0.00%	Rs150.00 ≈ $1.62	Rs513.55 Million ≈ $5.55 Million	--

pp = percentage points

About Par Drugs And Chemicals Limited

NSE:PAR India Drug Manufacturers - Specialty & Generic

Market Cap

$12.83 Million

Rs1.19 Billion INR

Market Cap Rank

#26415 Global

#1470 in India

Share Price

Rs96.40

Change (1 day)

+1.62%

52-Week Range

Rs78.58 - Rs118.56

All Time High

Rs348.45